Page 27 - Read Online
P. 27

from four phase III studies of botulinum neurotoxin type A‑ABO for the   Kerscher M, Ulmann C, Pavicic T. Botulinum toxin type A treatment to the
             treatment of glabellar lines. Aesthet Surg J 2009;29:S57‑65.  upper face: retrospective analysis of daily practice. Clin Cosmet Investig Dermatol
          15.  Rubin M, Dover J, Maas C, Nestor M. An analysis of safety data from five   2012;5:53‑8.
             phase III clinical trials on the use of botulinum neurotoxin type A‑ABO for   21.  Moy  R,  Maas  C,  Monheit  G,  Huber  MB,  Reloxin  Investigational  Group.
             the treatment of glabellar lines. Aesthet Surg J 2009;29:S50‑6.  Long‑term safety and efficacy of a new botulinum toxin type A in treating
          16.  Carruthers JD, Lowe NJ, Menter MA, Gibson J, Eadie N, Botox Glabellar   glabellar lines. Arch Facial Plast Surg 2009;11:77‑83.
             Lines II Study Group. Double‑blind, placebo‑controlled study of the safety   22.  Brandt F, Swanson N, Baumann L, Huber B. Randomized, placebo‑controlled
             and efficacy of botulinum toxin type A for patients with glabellar lines. Plast   study of a new botulinum toxin type a for treatment of glabellar lines: efficacy
             Reconstr Surg 2003;112:1089‑98.                      and safety. Dermatol Surg 2009;35:1893‑901.
          17.  Lowe PL, Patnaik R, Lowe NJ. A comparison of two botulinum type a toxin
             preparations for the treatment of glabellar lines: double‑blind, randomized,
             pilot study. Dermatol Surg 2005;31:1651‑4.        How to cite this article: Bank J, Phillips NA, Casas LA. Patient-
          18.  Prager W. Differential characteristics of incobotulinumtoxin A and its use in   centric dose equivalency pilot study of incobotulinumtoxin a (xeomin)
             the management of glabellar frown lines. Clin Pharmacol 2013;5:39‑52.  vs. abobotulinumtoxin a (dysport) in the treatment of glabellar frown
          19.  Carruthers A, Carruthers J. Commentary: long‑term treatment of glabellar   lines. Plast Aesthet Res 2015;2:12-6.
             rhytides using onabotulinumtoxina. Dermatol Surg 2011;37:929‑30.  Source of Support: Nil, Conflict of Interest: None declared.
          20.  Prager W, Huber‑Vorländer J, Taufig AZ, Imhof M, Kühne U, Weissberg R,   Received: 24-07-2014; Accepted: 28-09-2014
             Kuhr  LP,  Rippmann V,  Philipp‑Dormston WG,  Proebstle TM,  Roth  C,





































































            16                                                           Plast Aesthet Res || Vol 2 || Issue 1 || Jan 15, 2015
   22   23   24   25   26   27   28   29   30   31   32